Yahoo
LSE - Delayed Quote GBp

Advanced Medical Solutions Group plc (AMS.L)

282.50 0.00 (0.00%)
At close: October 30 at 4:35:17 PM GMT
Chart Range Bar
Loading chart for AMS.L
  • Previous Close 282.50
  • Open 283.00
  • Bid 282.50 x --
  • Ask 283.00 x --
  • Day's Range 282.50 - 283.00
  • 52 Week Range 187.00 - 284.50
  • Volume 484,660
  • Avg. Volume 1,705,968
  • Market Cap (intraday) 615.283M
  • Beta (5Y Monthly) 0.75
  • PE Ratio (TTM) 141.25
  • EPS (TTM) 0.02
  • Earnings Date (est.) --
  • Forward Dividend & Yield 0.01 (0.00%)
  • Ex-Dividend Date Sep 25, 2025
  • 1y Target Est 292.50

Advanced Medical Solutions Group plc, together with its subsidiaries, develops, manufactures, and distributes products for the surgical, woundcare, and wound-closure markets in the United Kingdom, Germany, France, Europe, the United States, and internationally. It offers surgical products, such as tissue adhesives, sutures and clips, haemostats, biosurgical, internal fixation devices, infection control, and internal sealants. The company also provides collagens, bone substitutes, resorbable fixation systems, vascular temporary occlusion, dressings, silicone wound contact layers, surgical supplies, debridement, hydrogels, and laparoscopic instruments. It sells its products under the LIQUIFIX, Peters Surgical, Ifabond, INTEGUSEAL, LiquiBand, RESORBA, LiquiBandFix8, Seal-G, Vitalitec, and ActivHeal brand names. The company provides wound care dressings, including silver alginates, alginates, and foams through its ActivHeal brand, as well as under white label. Advanced Medical Solutions Group plc was founded in 1991 and is headquartered in Winsford, the United Kingdom.

www.admedsol.com

1,800

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is FTSE 100 (^FTSE) .

YTD Return

AMS.L
29.59%
FTSE 100 (^FTSE)
8.04%

1-Year Return

AMS.L
30.18%
FTSE 100 (^FTSE)
9.94%

3-Year Return

AMS.L
47.02%
FTSE 100 (^FTSE)
46.43%

5-Year Return

AMS.L
13.04%
FTSE 100 (^FTSE)
48.25%

Analyst Insights

View More

Analyst Price Targets

275.00 Low
292.50 Average
282.50 Current
325.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    1.58%

  • Return on Assets (ttm)

    3.80%

  • Return on Equity (ttm)

    1.48%

  • Revenue (ttm)

    233.62M

  • Net Income Avi to Common (ttm)

    3.68M

  • Diluted EPS (ttm)

    0.02

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    13.56M

  • Total Debt/Equity (mrq)

    33.44%

  • Levered Free Cash Flow (ttm)

    5.94M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: